27 Apr Arthrexin 25 capsules (indomethacin 25mg)
| Company name & Address: |
registration number |
Batch number(s) |
Expiry date |
Pack size |
First distributed |
Re-call Classification |
Recall date |
| Pharmacare Limited t/a Aspen Pharmacare, Healthcare Park, Woodlands Drive, Woodmead, Sandton 2196, South Africa |
K/3.1/285 |
P0003739 |
Jan.2025 |
100’s |
Sep.2023 |
Class III Type C |
05.Feb.2024 |
Reason for recall
The recall was initiated because of an error of incorrect labelling found on some containers. The complainant (pharmacy) found Arthrexin 25 mg capsules in a container labelled as Arthrexin 50 mg capsules.
Advice to HCPs/Distributors/Public:
The company requested their clients to immediately return all unit containers to their wholesaler or distributor for a full credit, without delay.
Proposed action taken and its urgency: A SAHPRA approved recall letter was distributed to all distribution points and the recall process was initiated.
Reporting side effects
Public and healthcare professionals are encouraged to report any side effects after using a health product or after immunisation by using the Med Safety App. Your report will contribute to our monitoring of these health products.